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Abstract
In the literature, 51 cases of primary retroperitoneal mucinous cystadenocarcinoma have been
published. We report the fourth case occurring in a male patient. The 42-year-old patient presented
with multiple retroperitoneal cystic masses causing abdominal discomfort without alteration of the
global clinical state. The masses were totally removed by a two-stage surgery. No other treatment
has been introduced. After a follow-up of 6 months, the patient is disease-free. This rare tumor most
likely arises from the mucinous metaplasia of peritoneal inclusion cysts rather than from ectopic
ovarian tissue or ovarian teratomas. The occurrence of such a tumor in a male patient supports
this theory. Preoperative diagnosis is mostly difficult. Clinical behavior and treatment are still
controversial.
Introduction
Primary retroperitoneal mucinous cystadenocarcinoma
(PRMC) is an extremely rare tumor. To date, only
51 cases have been published. To our knowledge, this is
the fourth case ever reported in a male patient. The
pathogenesis remains unclear and controversial. Diagnosis
can often be confusing preoperatively. Surgeons must be
aware of this type of tumor and include it in their
differential diagnosis. Due to its rarity, optimal treatment,
survival and exact prognosis continue to be uncertain. We
report a case of PRMC in a 42-year-old man. A two-stage
surgical removal of all tumoral cysts has been performed.
Case presentation
A 42-year-old Moroccan man was initially seen in a private
structure for complaints of abdominal discomfort and
distension that lasted a year and a half. A notion of
smoking weaned 4 years ago was found in his history.
Prior physical examination found a large indolent right
hypochondrium mass. Both testes were descended and
were clinically normal. Biological tests, including Ca 19-9,
were strictly normal. On abdominal ultrasonography
(US), the mass was thought to be hydatid cyst of the
liver (Figure 1). At prior laparotomy, liver appeared
normal but five cystic and multilocular masses were
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between inferior veina cava and the abdominal aorta
bifurcation. Pancreas, spleen and kidneys were normal.
Total excision was performed for 3 masses. The other two
masses were inextirpable because of strong adherences to
vessels. The patient was then referred to our surgical unit
for complementary treatment.
Computed tomography (CT) showed residual retro-
peritoneal masses with cystic and tissular components,
spontaneously hyperdense (Figure 2). No enhancement
was observed after injection. Magnetic resonance imaging
(MRI) revealed multiple processes in the median retro-
peritoneum, extended from retro-cephalic pancreas to the
aortic bifurcation and intimately adherent to retroperito-
neal vessels without thrombosis. Hypersignal zones were
observed on T1 and T2 with fat suppression suggesting
a mucoid component. Some cysts showed carneous zones
slightly enhanced after gadolinium injection. Further-
more, pancreas was homogenous with no visible nodular
lesion. At the second laparotomy, 4 additional cystic
masses were discovered in the retroperitoneum aligned
from the duodenojejunal flexure to the aortic bifurcation.
There was no clear evidence that the masses were
originating from the pancreas or any other intra-abdom-
inal organs. Cystic masses were totally removed. They
appeared encapsulated, multicystic and filled with muci-
nous material (Figures 3-4). The largest one measured
5 × 4 × 3 cm. At histology, cystic wall contained some
smooth muscle fibres and was lined by a monostratified
epithelioma with mucin-producing columnar cells of the
intestinal type (Figure 5). Pluristratified foci with papillary
architecture and marked atypical cells were detected
signalising a borderline malignancy. Fibro-inflammatory
stroma was also noticed without invasive elements. This
histological pattern was similar to that reported after the
first surgical resection and suggested the diagnosis of
PRMC. No complication occurred in the postoperative
period and no adjuvant therapy has been instaured. There
was no evidence of recurrence, radiologically attested, after
6 months of follow-up.
Discussion
To date, only 51 cases of PRMC have been described. All
were females [1-4] but three occurred in male patients
[5-7]. We report the 52
th case and to our knowledge, it is
the fourth male patient with PRMC published in the
Figure 1. Abdominal ultrasound; cystic masses mimicking
liver hydatid cysts.
Figure 2. Computed tomography; retroperitoneal cystic
mass, spontaneously hyperdense, containing calcifications.
Figure 3. Macroscopic findings; four cystic masses, surgically
removed, surrounded by a capsule with a network of small
dilated vessels and without exophytic vegetations.
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Motoyama et al. (1994), with little mention of clinical
data andfollow-up [6]. The second malepatient, described
by Thamboo et al. (2006) [7] presented with a large
retroperitoneal cystic tumor measuring 24 × 20 × 16 cm,
which was removed intact. The third one was reported by
Green et al. (2007) with the largest tumor ever reported,
measuring 26 × 21 × 16 cm on CT [5].
Pathogenesis of these tumors remains unknown. First
hypothesis suggests that PRMCs arise from a retroperito-
neal monodermal teratoma, with predominant columnar
epithelium [8]. Other authors postulate an enterogenous
genesis because of intestinal duplication [9]. The
intestinal-like epithelioma and smooth muscles fibers
surrounding the cystic tumors in our case could support
this hypothesis. Because these tumors resemble ovarian
mucinous cystic neoplasms, the third explanation is that
they occur from ectopic ovarian tissue. Still no ovarian
tissue has ever been found within a PRMC [1,2]. The
fourth possibility is that the tumors are remnants of the
embryonal urogenital apparatus, in which the cysts
develop from specialized mesothelial cells of the urogen-
ital ridge [5]. The most widely accepted theory is that
PRMCs occur from invaginations of the peritoneal
epithelium during embryonic growth and subsequently
undergo metaplasia [10].Moreover, PRMC could originate
from undescended testis, what was excluded in our case.
Similarly to prior case reports, we were unable peropera-
tively to discover a pedicle or attachment to other organs.
Histologically, these tumors can be perplexing because
they present benign, borderline malignant and frankly
malignant areas [6]. The previous reported PRMCs tended
to be solitary and unilocular.
PRMCs often develop earlier in women with a mean age
at presentation of 42.4 years (range: 17-86), whereas the
diagnosis was assessed in the three previous male patients
at 83, 63 and 64 years respectively [5-7]. Our patient was
much younger with an age at onset of 42 years. The most
common symptom is abdominal discomfort and a slow-
growing pelvic or abdominal mass. In most cases, clinical
course appears to be indolent. However, these tumors can
become aggressive. Preoperative diagnosis is difficult
because of non-specific symptoms and the scarce aid of
imaging [11]. Tumor markers, such as CA-125 and CA19-9
are not very helpful due to their lake of specificity [12].
Differential diagnoses include metastatic mucinous
tumors from sites such as ovaries, intestines (including
the appendix) and pancreas. But also benign renal cystic
disease, renal lymphangioma or hydatid cysts. Needle
biopsy may be of use in these situations but is not a good
measure to determine malignancy in cystic tumors.
Management of PRMC is not well established. Clearly,
radical tumor excision is mandatory. Adjuvant chem-
otherapy has been attempted in some patients with
limited success [2,13]. Chemotherapy should be limited
to ruptured tumors during surgery [1,2] or when invasion
to adjacent structures is evident. Given the assumption
that PRMC arises in heterotopic ovarian tissue, many
authors advise hysterectomy with bilateral salpingo-
oophorectomy, either simultaneously or later at re-
exploratory laparotomy [1,14]. In these cases, the resected
genital organs showed no evidence of tumor infiltration
and the follow-up of these patients is yet too short to
Figure 4. Macroscopic findings; multicystic aspect at
sectioning, with mucoid content.
Figure 5. Microscopic findings; cystic wall was containing
smooth muscle fibers and was lined by a monostratified
mucinous type epithelium (hematoxilin and eosin, 20×).
Papillary pseudostratification was also observed.
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recommend adjuvant hysterectomy and bilateral
salpingo-oophorectomy restricted to women who have
completed their child bearing or are postmenopausal [1].
Prognosis of these tumors remains uncertain because of
their rarity and the short follow-up of the patients. The
longest reported follow-up is 6 years in women [15] and
18 months in men [7]. Presence of a mural nodule within
the cyst wall could worsen prognosis [13]. It is also
difficult to determine whether these tumors have a similar
clinical behavior and prognosis in men and women. None
of the patients who died or received chemotherapy were
men. Long-term follow-up after surgical removal of this
unusual tumor with ultrasound or CT scanning appears
thus essential.
Conclusion
PMRC usually presents with mass effects, have an indolent
course but can become very large or possess aggressive
clinical course. Diagnosis remains difficult preoperatively
and surgeons must be aware of PRMC as a differential
diagnosis of a large retroperitoneal cystic mass. Clinical
behavior and treatment of PRMC still are controversial.
To date, extirpative surgery appears to be the standard
treatment and the role of adjuvant radiation or che-
motherapy has yet to be determined. Further studies are
needed to establish optimal treatment protocols.
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